Immunotherapy for Contact Dermatitis Using Co-signal Regulation

Compounds, compositions and methods for immunotherapy in contact dermatitis. Compounds and compositions (e.g. monoclonal antibodies) that stimulate the LAIR-1 expression pathway in LAIR-1 expressing immune cells and are useful for preventing or treating contact dermatitis are provided.

Attached files:


Patents:
WO 2,010,078,580

Inventor(s): TAMADA KOJI [US]

Type of Offer: Licensing



« More Medical Patents

---